The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1497
ISSUE1497
June 20, 2016
A New Abuse-Deterrent Opioid - Xtampza ER
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A New Abuse-Deterrent Opioid - Xtampza ER
June 20, 2016 (Issue: 1497)
The FDA has approved Xtampza ER (Collegium),
a new extended-release, abuse-deterrent capsule
formulation of oxycodone, for management of pain
severe enough to require daily, around-the-clock,
long-term opioid treatment and for which...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.